PHARMACOLOGICAL PRECONDITIONING. FOCUS ON NICORANDIL

PHARMACOLOGICAL PRECONDITIONING. FOCUS ON NICORANDIL

The review focuses on the gathered data related to preconditioning phenomenon and, particularly, pharmacological preconditioning of myocardium. The information presented, on the activator of ATP-dependent potassium channels nicorandil. Mechanism of action is discussed, as efficacy and safety data. T...

Full description

Bibliographic Details
Main Authors:	R. V. Gostishchev, G. N. Soboleva, A. N. Samko, A. G. Osiev
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2017-10-01
Series:	Российский кардиологический журнал
Subjects:	pharmacological preconditioning of myocardium nicorandil activator of atp-dependent potassium channels percutaneous coronary interventions cardiac enzymes
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/2543

Similar Items

The periprocedural myocardial damage prevention during elective percutaneous coronary intervention as a result of pharmacological preconditioning with an oral form of nicorandil in patients with stable coronary artery disease. Pilot study
by: R V Gostishchev, et al.
Published: (2018-09-01)

The Effect of Pharmacological Preconditioning with Nicorandil before Elective Coronary Stenting on the Long-Term Prognosis of Patients with Stable Coronary Artery Disease
by: G. N. Soboleva, et al.
Published: (2020-05-01)

Nicorandil in the prevention of cardiac damage and type 4A myocardial infarction with planned percutaneous coronary intervention in patients with atherosclerosis of coronary arteries
by: G. N. Soboleva, et al.
Published: (2019-06-01)

Effects of Nicorandil on the Clinical and Laboratory Outcomes of Unstable Angina Patients after Coronary Angioplasty
by: Homa Falsoleiman, et al.
Published: (2016-09-01)

Effect of nicorandil on QT dispersion in patients with stable angina pectoris undergoing elective angioplasty: A triple-blind, randomized, placebo-controlled study
by: Homa Fal Suleimani, et al.
Published: (2017-08-01)

Intracoronary nicorandil induced hyperemia for physiological assessments in the coronary artery lesions
by: Xia Yang, et al.
Published: (2022-11-01)

Efficacy and safety of nicorandil on perioperative myocardial injury in patients undergoing elective percutaneous coronary intervention: results of the PENMIPCI trial
by: Ye Z, et al.
Published: (2018-08-01)

Molecular Bases of Brain Preconditioning
by: Oleg G. Deryagin, et al.
Published: (2017-07-01)

Meta-analysis of Nicorandil effectiveness on myocardial protection after percutaneous coronary intervention
by: Xiao-Tao Zhao, et al.
Published: (2019-06-01)

STUDY OF EFFECT PREKONDITSIONIRUYUSCHEGO RESVERATROL AND NICORANDIL IN THE CORRECTION OF ADMA-LIKE PRE-ECLAMPSIA
by: V. V. Gureev, et al.
Published: (2016-10-01)

Nicorandil-induced penile ulcerations: A case report and review of the penile cutaneous circulation
by: C.D. Jones, et al.
Published: (2016-09-01)

Cardiac preconditioning and cardiovascular diseases
by: William A Li, et al.
Published: (2017-01-01)

Nicorandil in patients with acute coronary syndrome and stable angina undergoing percutaneous coronary intervention: literature review
by: Neda Partovi, et al.
Published: (2015-01-01)

Nicorandil in patients with acute coronary syndrome and stable angina undergoing Percutaneous Coronary Intervention: literature review
by: Neda Partovi, et al.
Published: (2014-12-01)

Mechanism of action and neuroprotective role of nicorandil in ischemic stroke
by: Maryam Owjfard, et al.
Published: (2024-02-01)

TADALAFIL AS AN AGENT OF PHARMACOLOGICAL PRECONDITIONING IN ISCHEMIC – REPERFUSION BRAIN INJURY
by: Olga Martynova
Published: (2017-09-01)

Effect of long-term nicorandil therapy on myocardial perfusion parameters according to triphosadenine stress-volume computed tomography in a patient with non-obstructive coronary artery disease: a care report
by: O. F. Egorkina, et al.
Published: (2023-10-01)

Nicorandil directly and cyclic GMP-dependently opens K+ channels in human bypass grafts
by: Marija Marinko, et al.
Published: (2015-06-01)

Pharmacological Preconditioning Using Diazoxide Regulates Store-Operated Ca2 + Channels in Adult Rat Cardiomyocytes
by: Raúl Sampieri, et al.
Published: (2020-01-01)

Association between Ranolazine, Ischemic Preconditioning, and Cardioprotection in Patients Undergoing Scheduled Percutaneous Coronary Intervention
by: Konstantinos Kourtis, et al.
Published: (2024-01-01)

Routes for Potassium Ions across Mitochondrial Membranes: A Biophysical Point of View with Special Focus on the ATP-Sensitive K<sup>+</sup> Channel
by: Yevheniia Kravenska, et al.
Published: (2021-08-01)

Nicorandil prior to primary percutaneous coronary intervention improves clinical outcomes in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials
by: Xu L, et al.
Published: (2019-04-01)

Cardioprotective effect of nicorandil on isoproterenol induced cardiomyopathy in the Mdx mouse model
by: Rachel T. Sullivan, et al.
Published: (2021-06-01)

Effects of Nicorandil on Inflammation, Apoptosis and Atherosclerotic Plaque Progression
by: Max Lenz, et al.
Published: (2021-01-01)

Protective role of single versus multiple remote ischemic preconditioning in elective percutaneous coronary interventions
by: Alaa Mabrouk Salem Omar, et al.
Published: (2015-12-01)

Mechanisms and Prospects of Ischemic Tolerance Induced by Cerebral Preconditioning
by: Mohammad Iqbal Hossain Bhuiyan, et al.
Published: (2010-12-01)

Nicorandil decreases oxidative stress in slow‐ and fast‐twitch muscle fibers of diabetic rats by improving the glutathione system functioning
by: Sarai Sánchez‐Duarte, et al.
Published: (2021-07-01)

Metabolic model for laboratory control of anti-ischaemic therapy effectiveness: a case study of nicorandil
by: T. F. Subbotina, et al.
Published: (2023-12-01)

Effects of nicorandil on renal function and histopathology in rats with partial unilateral ureteral obstruction
by: Hayrettin Ozturk, et al.
Published: (2017-05-01)

MODERN PHARMACOTHERAPY OF THE STABLE ANGINA: POSSIBILITIES AND PROSPECTS OF NICORANDIL IMPLEMENTATION
by: Z. M. Sizova, et al.
Published: (2016-01-01)

Morphofunctional changes in the myocardium of the rat heart ventricles with noncoronarogenic necrosis in different stages of ischemic precondition
by: Stanishevskaya N.V.
Published: (2015-12-01)

Pharmacological rescue of trafficking-impaired ATP-sensitive potassium channels
by: Gregory M. Martin, et al.
Published: (2013-12-01)

Combined Systemic Intake of K-ATP Opener (Nicorandil) and Mesenchymal Stem Cells Preconditioned With Nicorandil Alleviates Pancreatic Insufficiency in a Model of Bilateral Renal Ischemia/Reperfusion Injury
by: Asmaa Mohammed ShamsEldeen, et al.
Published: (2022-06-01)

The Safety of Nicorandil Therapy and the Relationship with Treatment Adherence in Patients with Stable Angina Pectoris (According to the NIKEA Observational Study)
by: Yu. V. Lukina, et al.
Published: (2022-09-01)

Exploring the Pathophysiology of ATP-Dependent Potassium Channels in Insulin Resistance
by: Nidia Samara Rodríguez-Rivera, et al.
Published: (2024-04-01)

ORAL TREATMENT WITH NICORANDIL AT DISCHARGE IS ASSOCIATED WITH REDUCED MORTALITY AFTER ACUTE MYOCARDIAL INFARCTION
by: Y. Sakata, et al.
Published: (2012-10-01)

ASSESSMENT OF ADHERENCE TO TREATMENT AND FACTORS AFFECTING IT IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE DURING THERAPY WITH NICORANDIL
by: S. Yu. Martsevich, et al.
Published: (2017-12-01)

Nicorandil Improves Left Ventricular Myocardial Strain in Patients With Coronary Chronic Total Occlusion
by: Shaomin Chen, et al.
Published: (2022-05-01)

Clinical outcomes of nicorandil administration in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials
by: Ning Geng, et al.
Published: (2021-10-01)

Therapeutic potential of nicorandil beyond anti-anginal drug: A review on current and future perspectives
by: Dhirendra Singh, et al.
Published: (2024-04-01)